» Articles » PMID: 28018557

A Hybrid Computer-aided-diagnosis System for Prediction of Breast Cancer Recurrence (HPBCR) Using Optimized Ensemble Learning

Overview
Specialty Biotechnology
Date 2016 Dec 27
PMID 28018557
Citations 31
Authors
Affiliations
Soon will be listed here.
Abstract

Cancer is a collection of diseases that involves growing abnormal cells with the potential to invade or spread to the body. Breast cancer is the second leading cause of cancer death among women. A method for 5-year breast cancer recurrence prediction is presented in this manuscript. Clinicopathologic characteristics of 579 breast cancer patients (recurrence prevalence of 19.3%) were analyzed and discriminative features were selected using statistical feature selection methods. They were further refined by Particle Swarm Optimization (PSO) as the inputs of the classification system with ensemble learning (Bagged Decision Tree: BDT). The proper combination of selected categorical features and also the weight (importance) of the selected interval-measurement-scale features were identified by the PSO algorithm. The performance of HPBCR (hybrid predictor of breast cancer recurrence) was assessed using the holdout and 4-fold cross-validation. Three other classifiers namely as supported vector machines, DT, and multilayer perceptron neural network were used for comparison. The selected features were diagnosis age, tumor size, lymph node involvement ratio, number of involved axillary lymph nodes, progesterone receptor expression, having hormone therapy and type of surgery. The minimum sensitivity, specificity, precision and accuracy of HPBCR were 77%, 93%, 95% and 85%, respectively in the entire cross-validation folds and the hold-out test fold. HPBCR outperformed the other tested classifiers. It showed excellent agreement with the gold standard (i.e. the oncologist opinion after blood tumor marker and imaging tests, and tissue biopsy). This algorithm is thus a promising online tool for the prediction of breast cancer recurrence.

Citing Articles

Harnessing artificial intelligence for predicting breast cancer recurrence: a systematic review of clinical and imaging data.

Silveira J, da Silva A, de Lima M Discov Oncol. 2025; 16(1):135.

PMID: 39921795 PMC: 11807043. DOI: 10.1007/s12672-025-01908-6.


Prediction of breast cancer Invasive Disease Events using transfer learning on clinical data as image-form.

Fanizzi A, Bove S, Comes M, Di Benedetto E, Latorre A, Giotta F PLoS One. 2024; 19(11):e0312036.

PMID: 39570983 PMC: 11581389. DOI: 10.1371/journal.pone.0312036.


Deep learning empowered breast cancer diagnosis: Advancements in detection and classification.

Ahmad J, Akram S, Jaffar A, Ali Z, Bhatti S, Ahmad A PLoS One. 2024; 19(7):e0304757.

PMID: 38990817 PMC: 11239011. DOI: 10.1371/journal.pone.0304757.


Classification of white blood cells (leucocytes) from blood smear imagery using machine and deep learning models: A global scoping review.

Asghar R, Kumar S, Shaukat A, Hynds P PLoS One. 2024; 19(6):e0292026.

PMID: 38885231 PMC: 11182552. DOI: 10.1371/journal.pone.0292026.


Employing Atrous Pyramid Convolutional Deep Learning Approach for Detection to Diagnose Breast Cancer Tumors.

Sadeghi Pour E, Esmaeili M, Romoozi M Comput Intell Neurosci. 2023; 2023:7201479.

PMID: 38025486 PMC: 10663704. DOI: 10.1155/2023/7201479.


References
1.
Gonzalez-Angulo A, Litton J, Broglio K, Meric-Bernstam F, Rakkhit R, Cardoso F . High risk of recurrence for patients with breast cancer who have human epidermal growth factor receptor 2-positive, node-negative tumors 1 cm or smaller. J Clin Oncol. 2009; 27(34):5700-6. PMC: 2792998. DOI: 10.1200/JCO.2009.23.2025. View

2.
de Martel C, Ferlay J, Franceschi S, Vignat J, Bray F, Forman D . Global burden of cancers attributable to infections in 2008: a review and synthetic analysis. Lancet Oncol. 2012; 13(6):607-15. DOI: 10.1016/S1470-2045(12)70137-7. View

3.
Dietterich . Approximate Statistical Tests for Comparing Supervised Classification Learning Algorithms. Neural Comput. 1998; 10(7):1895-1923. DOI: 10.1162/089976698300017197. View

4.
Dunnwald L, Rossing M, Li C . Hormone receptor status, tumor characteristics, and prognosis: a prospective cohort of breast cancer patients. Breast Cancer Res. 2007; 9(1):R6. PMC: 1851385. DOI: 10.1186/bcr1639. View

5.
Narod S . Tumour size predicts long-term survival among women with lymph node-positive breast cancer. Curr Oncol. 2012; 19(5):249-53. PMC: 3457875. DOI: 10.3747/co.19.1043. View